Showing all 4 results
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 20mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 20mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 30mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 30mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
A 30mg Tirzepatide research cartridge, reconstituted for consistent precision.
– Twelve 2.5mg doses or thirty 1mg doses
– Purity Pen compatible
– Shipped with cold pack
– For research use only
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
A 30mg Tirzepatide research cartridge, reconstituted for consistent precision.
– Twelve 2.5mg doses or thirty 1mg doses
– Purity Pen compatible
– Shipped with cold pack
– For research use only
